In an effort to increase awareness about the current COVID-19 pandemic and vaccination process, Ali Bin Ali (ABA) Holding organized a special live webinar on the topic for all its staff. The virtual event was held on March 10, 2021, from 4pm to 5pm. It was arranged in collaboration with Bangladesh Forum Qatar and doctors from Hamad Medical Corporation.
The session was headed by Dr. Akhnuwkh Jones, Sr. Consultant, Hamad General Hospital; and Dr. Mashuk Uddin, Sr. Consultant Physician and Associate Professor, Hamad Medical Corporation.
It was a valuable opportunity for the ABA staff members to get information and answers from the experts. Employees from different divisions of the conglomerate took a break from their busy work schedule to participate in this very important webinar session, which not only helped them gather information about the coronavirus but also allowed them to clear misunderstandings and misbeliefs about the same.
The agenda for the webinar was divided into three parts. The first part included an explanation about what exactly is COVID-19, how it spreads, what are the preventive measures and information about the variants of the virus.
The second part mainly dealt with insights about the vaccines for COVID-19. Apart from sharing information on how the vaccines were created, the science behind the vaccines and why they work, the doctors also clarified misconceptions around the vaccines.
The third and final part aimed at raising awareness about the spread of COVID-19 through next degrees (second- and third-degree contact) and community living. The webinar was wrapped up with a question-and-answer session.
Thanking the doctors and all attendees for the event, ABA Group General Manager – Human Resources Mr. Aldrine Fernandez said: “ABA Holding has been taking every possible step to raise awareness and protect our staff from the pandemic. However, we realized that apart from raising awareness, it is important to address the concerns and questions of our staff about the virus. The webinar has not only added to our knowledge about COVID-19 but also provided an insight about the current situation, future expectations and scope of the vaccines.”